DCF — VANDERBILT UNIVERSITY MEDICAL CENTER
Enterprise Value: $-13.1B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-13.1B
Enterprise Value
$-4.1B
PV of Cash Flows
$-9.0B
PV of Terminal Value
$-14.5B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $5.6B | $-862.2M | -15.0% | $-1.1B | $-999.5M |
| Year 2 | $5.8B | $-830.3M | -14.0% | $-1.1B | $-888.2M |
| Year 3 | $5.9B | $-795.8M | -13.0% | $-1.0B | $-787.0M |
| Year 4 | $6.1B | $-789.0M | -13.0% | $-1.0B | $-716.0M |
| Year 5 | $6.3B | $-796.9M | -13.0% | $-1.1B | $-660.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-13.1B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$5.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1588226963925704
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5